Adjusting life for quality or disability: Stylistic difference or substantial dispute?

Health Economics

Volumn 18, Issue 11, 2009, Pages 1237-1247

  Mara, Airoldi ^a   Alec, Morton ^a  

^a LONDON SCHOOL OF ECONOMICS   (United Kingdom)

Author keywords

DALY; Economic evaluation; QALY

Indexed keywords

AGE; ARTICLE; COST EFFECTIVENESS ANALYSIS; DAILY LIFE ACTIVITY; DISABILITY; HEALTH CARE PLANNING; HEALTH CARE UTILIZATION; HEALTH ECONOMICS; HUMAN; LIFE EXPECTANCY; METHODOLOGY; MORTALITY; PRIORITY JOURNAL; QUALITY ADJUSTED LIFE YEAR;

ACTIVITIES OF DAILY LIVING; ALGORITHMS; DISABILITY EVALUATION; DISABLED PERSONS; HEALTH STATUS; HUMANS; QUALITY-ADJUSTED LIFE YEARS;

EID: 70350780744     PISSN: 10579230     EISSN: 10991050     Source Type: Journal    
DOI: 10.1002/hec.1424     Document Type: Article

References (41)

1. Anand S, Hanson K. 1997. Disability-adjusted life years: a critical review. Journal of Health Economics 16: 685-702.
2. Andrews G, Issakidis C, Sanderson K, Corry J, Lapsey H. 2004. Utilising survey data to inform public policy: comparison of the cost-effectiveness of treatment of ten mental disorders. British Journal of Psychiatry 184: 526-533.
3. Atkinson AB. 1987. On the measurement of poverty. Econometrica 55: 749-764.
4. Bevan G, Hollinghurst S. 2003. Cost per quality adjusted life year and disability adjusted life years: the need for a new paradigm. Expert Review of Pharmacoeconomics and Outcomes Research 3: 469-477. (Pubitemid 36975094)
5. Centre for Economic Performance's Mental Health Policy Group. 2006. The Depression Report: A New Deal for Depression and Anxiety Disorders. Centre for Economic Performance, LSE: London.
6. Chisholm D. 2005. Choosing cost-effective interventions in psychiatry: results from the CHOICE programme of the World Health Organisation. World Psychiatry 4: 37-44.
7. Coale A, Demeny P. 1983. Regional Model Life Tables and Stable Populations. Princeton University Press, Princeton: New York.
8. Dawson D, Gravelle H, O'Mahony M, Street A, Weale M, Castelli A, Jacobs R, Kind P, Loveridge P, Martin S, Stevens P, Stokes L. 2005. Developing new approaches to measuring NHS outputs and productivity. Report RP6: York, University of York Centre for Health Economic.
9. Department of Health. 2005. Healthcare Output and Productivity: Accounting for Quality Change. Department of Health, London.
10. Drummond KF, Sculpher MJ, Torrance GW, O'Brien BJ, Stoddart GL. 2005. Methods for the Economic Evaluation of Health Care Programmes. OUP: Oxford.
11. Fanshel S, Bush J. 1970. A Health-Status Index and its application to health-services outcomes. Operations Research 18: 1021-1066.
12. Fox-Rushby JA. 2002. Disability-Adjusted Life Years (DALYs) for Decision Making? An Overview of the Literature. Office of Health Economics, London.
13. GAD. 2006. Interim Life Tables 2003-2005, England 2007.
14. Garber AM, Weinstein MC, Torrance GW, Kamlet MS. 1996. Theoretical foundations of cost-effectiveness Analysis. In Cost-Effectiveness in Health and Medicine 1996, Gold MR, Siegel JE, Russell LB, Weinstein MC (eds). OUP: Oxford.
15. Gold MR, Siegel JE, Russell LB, Weinstein MC. 1996. Cost-effectiveness in Health and Medicine. Oxford University Press: New York.
16. Gold MR, Stevenson D, Fryback DG. 2002. HALYs and QALYs and DALYs, Oh my: similarities and differences in summary measures of population health. Annual Review of Public Health 23: 115-134. (Pubitemid 34508069)
17. Goldman N, Lord G. 1986. A new look at entropy and the life table. Demography 23: 275-282.
18. Hollinghurst S, Bevan G, Bowie C. 2000. Estimating the avoidable burden of disease by Disability Adjusted Life Years (DALYs). Health Care Management Science 3: 9-21.
19. Hutubessy R, Chisholm D, Edejer TT-T, WHO-CHOICE. 2003. Generalised cost-effectiveness analysis for national-level priority setting in the health sector. Cost Effectiveness and Resource Allocation 1(1): 8-20.
20. Johannesson M, Pliskin JS, Weinstein MC. 1994. A note on QALYs, time tradeoff, and discounting. Medical Decision Making 14: 188-193.
21. Keyfitz N. 1968. Introduction to the Mathematics of Population. Addison-Wesley: Reading, MA.
22. Lindsey J. 2004. Statistical Analysis of Stochastic Processes in Time. Cambridge University Press: Cambridge.
23. Maynard A, Bloor K, Freemantle N. 2004. Challenges for the national institute for clinical excellence. British Medical Journal 329: 227-229. (Pubitemid 39013285)
24. Melse JM, Essink-Bot ML, Kramers PGN, Hoeymans N. 2000. A national burden of disease calculation: Dutch disability-adjusted life years. American Journal of Public Health 90: 1241-1247. (Pubitemid 30497377)
25. Mooney G, Wiseman V. 2000. Burden of disease and priority setting. Health Economics 9: 369-372.
26. Murray CJL. 1996. Rethinking DALYs. In The Global Burden of Disease: A Comprehensive Assessment of Mortality and Disability from Diseases, Injuries and Risk Factors in 1990 and Projected to 2020, Murray CJL, Lopez AD (eds). Harvard School of Public Health, WHO, World Bank: Cambridge, MA; 1-98.
27. Murray CJL, Acharya AK. 1997. Understanding DALYs. Journal of Health Economics 16: 703-730.
28. Murray CJL, Lopez AD. 1997. The utility of DALYs for public health policy and research: a reply. Bulletin of the World Health Organisation 75: 377-381.
29. Murray CJL, Lopez AD. 2000. Progress and directions in refining the global burden of disease approach: a response to Williams. Health Economics 9: 69-82.
30. National Institute for Health and Clinical Excellence. 2006. The Guidelines Manual. National Institute for Health and Clinical Excellence.
31. National Institute for Health and Clinical Excellence. 2008. Updated guide to the methods of technology appraisal - June 2008. National Institute for Health and Clinical Excellence.
32. Østerdahl LP. 2005. Axioms for healthcare resource allocation. Journal of Health Economics 24: 679-702.
33. Pliskin JS, Shepard DS, Weinstein MC. 1980. Utility functions for life years and health status. Operations Research 28: 206-224.
34. Preston SH. 1993. Health indices as a guide to health sector planning: a demographic critique. In The Epidemiological Transition: Policy and Planning Implications for Developing Countries 1993, edited by James N. Gribble and Samuel H. Preston. National Academy Press: Washington, DC; 126-144.
35. Shrestha LB. 2005. Life expectancy in the United States. CRS Report for Congress.
36. Tan-Torres Edejer T, Baltussen R, Adam T, Hutubessy R, Acharya A, Evans D, Murray CJL. 2003. Making Choices in Health: WHO Guide to Cost-Effectiveness Analysis. Geneva: World Health Organization.
37. Weinstein MC, Stason WB. 1977. Foundations of cost-effectiveness analysis for health and medical practices. New England Journal of Medicine 296: 716-721. (Pubitemid 8066534)
38. Williams A. 1985. Economics of coronary artery bypass grafting. British Medical Journal 291: 326-329. (Pubitemid 15045122)
39. Williams A. 1997. Intergenerational equity: an exploration of the 'fair innings' argument. Health Economics 6: 117-132.
40. Williams A. 1999. Calculating the global burden of disease: time for a strategic reappraisal. Health Economics 8: 1-8. (Pubitemid 29057351)
41. World Bank. 1993. World Development Report 1993: Investing in Health. Oxford University Press: Oxford.